PacBio has announced the commencement of external beta testing of the Onso™ Sequencing System.

Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace and productivity of Alnylam’s RNAi therapeutics pipeline.

Ubiquigent Limited today announced the appointment of Dr. Sheelagh Frame, Chief Scientific Officer, to the Company’s Board of Directors.

Fortis Life Sciences has expanded its international presence by opening an office in Seoul, South Korea.

The Medical Device Innovation Consortium has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples to simplify and support the validation of next-generation sequencing-based cancer diagnostics.

The UK’s largest annual trade show for the lab industry, Lab Innovations will focus on the theme of sustainability at this year’s show, taking place on November 2 and 3 at the NEC, Birmingham.

Beckman Coulter Life Sciences will have a full team of dedicated professionals and informative programming at the American Society of Human Genetics (ASHG) Annual Meeting October 25-29, 2022 in Los Angeles, California at the Los Angeles Convention Center.

Beckman Coulter Life Sciences introduces an automated solution for the grueling and time-consuming process of manual gating flow cytometry data, with no programming skills required.

EKF Diagnostics announces an enhanced DiaSpect Tm, that now connects securely to the company’s own point-of-care middleware, enabling additional features including a calculated hematocrit value and data management.

Autoscribe Informatics will be demonstrating their new LIMS Web application at Lab Innovations 2022, the UK’s largest dedicated exhibition for laboratory professionals.